From 2008 to 2016 — after the introduction of prasugrel and ticagrelor — the percentage of patients who did not fill a prescription for a P2Y12 inhibitor within 30 days of hospital discharge after PCI increased significantly, according to an analysis of administrative claims database from a national health insurer.
“Speaking from the perspective of an interventional cardiologist, these are extremely disturbing data,” study researcher Jay Giri, MD, MPH, director of peripheral intervention and assistant professor of medicine at the Hospital of the University of Pennsylvania and a Cardiology Today Next Gen Innovator, told Cardiology Today’s Intervention.
This activity is supported by an educational grant from Radius Health, Inc.
Search Healio's robust listing of national and international medical meetings.
Tell us what you think about Healio.com »
Get the latest news and education delivered to your inbox
©2018 Healio All Rights Reserved.